SKIN HAIR NAILS
Natural health product licensed in Canada
- Licence holder
- HOLDING AGD
- NPN or DIN-HM
- 80111162
- Status
- Active licence
- Licence date
- 5 July 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 0.7 mg | Not calculated |
| Agaricus blazei Source : Corps fructifère Potency : 15 % beta-glucan | 10 mg | Not calculated |
| Vitamine B6 Source : Pyridoxine | 0.7 mg | Not calculated |
| Myrciaria dubia Source : Fruit Potency : 50 % Vitamin C | 30 mg | Not calculated |
| Niacine Source : Niacinamide | 8 mg | Not calculated |
| Sélénium Source : Sélénite de sodium | 18 mcg | Not calculated |
| Zinc Source : Gluconate de zinc | 11 mg | Not calculated |
| Panicum miliaceum Source : Graine | 100 mg | Not calculated |
| Eruca sativa Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 240 mg | 60 mg | Not calculated |
| Ascophyllum nodosum Source : En entier Potency : 0.1 % Iodine | 60 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 mg | 20 mg | Not calculated |
| Arctium lappa Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 80 mg | 20 mg | Not calculated |
| Biotine Source : Biotine | 30 mcg | Not calculated |
| Agaricus blazei Source : Corps fructifère Potency : 30 % Polysaccharides | Not specified | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Mannitol, Xylitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 par jour ; maximum: 2 par jour |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of fungal polysaccharides with immunomodulating properties. A factor in the maintenance of good health and normal growth and development. Contributes to maintaining general health. Helps in connective tissue formation. Helps in energy metabolism and in tissue formation. Helps maintain healthy skin and connective tissue formation. Helps to form red blood cells. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain normal function of the thyroid gland. Helps to maintain the body's ability to metabolize nutrients. Helps with immune function. Maintains healthy hair, skin and nails. Multi-vitamin supplement. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Supports good health. Vitamin supplement. Source of/ Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80111162
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
- Arctium lappa
Read the warning, when it applies and the studies cited
Burdock - Arctium Lappa - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
Health Canada monograph dated 19 December 2025
BURDOCK - ARCTIUM LAPPA - Topical
Cautions and warnings
For external use only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.